12:00 AM
 | 
Jun 11, 2012
 |  BC Week In Review  |  Company News  |  Deals

Foamix, Telormedix deal

The companies received €947,617 ($1.2 million) in funding from the Eureka-Eurostars program to coordinate a two-year research project named TOSCA aimed at developing new topical treatments for skin cancer based on a foam formulation of Telormedix's...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >